A detailed history of State Of New Jersey Common Pension Fund D transactions in Repligen Corp stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 19,318 shares of RGEN stock, worth $2.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,318
Previous 30,726 37.13%
Holding current value
$2.82 Million
Previous $5.65 Million 56.91%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$120.0 - $182.95 $1.37 Million - $2.09 Million
-11,408 Reduced 37.13%
19,318 $2.44 Million
Q3 2023

Nov 08, 2023

SELL
$138.78 - $176.51 $147,106 - $187,100
-1,060 Reduced 3.33%
30,726 $4.89 Million
Q2 2022

Aug 04, 2022

BUY
$140.68 - $188.02 $126,752 - $169,406
901 Added 2.92%
31,786 $5.16 Million
Q4 2021

Jan 31, 2022

SELL
$247.59 - $304.47 $31,443 - $38,667
-127 Reduced 0.41%
30,885 $8.18 Million
Q3 2021

Oct 27, 2021

BUY
$194.77 - $324.21 $21,424 - $35,663
110 Added 0.36%
31,012 $8.96 Million
Q2 2021

Jul 23, 2021

SELL
$165.87 - $220.95 $73,148 - $97,438
-441 Reduced 1.41%
30,902 $6.17 Million
Q1 2021

Apr 27, 2021

SELL
$180.37 - $226.26 $348,294 - $436,908
-1,931 Reduced 5.8%
31,343 $6.09 Million
Q4 2020

Feb 03, 2021

SELL
$148.08 - $206.57 $271,134 - $378,229
-1,831 Reduced 5.22%
33,274 $6.38 Million
Q3 2020

Oct 27, 2020

SELL
$122.51 - $158.27 $165,633 - $213,981
-1,352 Reduced 3.71%
35,105 $5.18 Million
Q2 2020

Aug 04, 2020

SELL
$94.33 - $140.48 $281,480 - $419,192
-2,984 Reduced 7.57%
36,457 $4.51 Million
Q4 2019

Jan 31, 2020

BUY
$73.84 - $93.08 $128,555 - $162,052
1,741 Added 4.62%
39,441 $3.65 Million
Q3 2019

Oct 23, 2019

BUY
$76.65 - $95.51 $2.89 Million - $3.6 Million
37,700 New
37,700 $2.89 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.1B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.